Skip to Content
Robert ODoherty PhD
  • Robert O'Doherty, PhD

    Professor of Medicine Professor of Biochemistry and Molecular Genetics Director, T32 Diabetes and Endocrinology Training Program Co-Director, Center for Metabolic and Mitochondrial Medicine (C3M) Email: rmo1@pitt.edu Phone: 412-648-3320

Robert O'Doherty, PhD

Professor of Medicine Professor of Biochemistry and Molecular Genetics Director, T32 Diabetes and Endocrinology Training Program Co-Director, Center for Metabolic and Mitochondrial Medicine (C3M) Email: rmo1@pitt.edu Phone: 412-648-3320

Profile:

Professor of Medicine
Professor of Biochemistry and Molecular Genetics
Director, T32 Diabetes and Endocrinology Training Program
Co-Director, Center for Metabolic and Mitochondrial Medicine (C3M)
Email: rmo1@pitt.edu
Phone: 412-648-3320

Office:
W1059 Biomedical Science Tower
200 Lothrop Street
Pittsburgh, PA 15213
Phone: 412-648-3320
Fax: 412-648-3290

Education
B.A., University of Dublin, 1986
PhD, Vanderbilt University, 1995

Training
Postdoctoral Fellow, Diabetes/Obesity, University of Texas, Southwestern Medical Center, 1998

Research Interest
Dr. O'Doherty's overarching research interests are in questions related to the association between states of over nutrition and resulting metabolic disturbances, most notably obesity, NAFLD, and Type 2 Diabetes. Dr. O'Doherty has accumulated nearly twenty five years experience in this arena, utilizing a range of metabolic, physiological, biochemical, molecular and immunological approaches in a range of models, notably the mouse and rat, primary tissue culture, and immortal cell lines. The major foci of his current research efforts are in the area of immunometabolism, that is the role of immune system in the regulation of metabolism.

Publications
He, J., Gao, J., Xu, M., Ren, S., Stefanovic-Racic, M., O'Doherty, R.M., Xie, W. PXR ablation alleviates diet-induced and genetic obesity and insulin resistance in mice. Diabetes. 2013; 62(6): 1876-87.

Shi, X., Cheng, Q., Xu, L., Yan, J., Jiang, M., He, J., Xu, M., Stefanovic-Racic, M., Sipula, I.J., O'Doherty, R.M., Ren, S., Xie, W. Cholesterol sulfate and cholesterol sulfotransferase inhibit gluconeogenesis by targeting hepatocyte nuclear factor 4a. Molecular and Cellular Biology. 2014; 34(3): 485-97.

Jiang, M., He, J., Kucera, H., Gaikwad, N.W., Zhang, B., Xu, M., O'Doherty, R.M., Selcer, K.W., Xie, W. Hepatic overexpression of steroid sulfatase ameliorates mouse models of obesity and type 2 diabetes through sex-specific mechanisms. The Journal of Biological Chemistry. 2014; 289(12): 8086-97.

Avin, K.G., Coen, P.M., Huang, W., Stolz, D.B., Sowa, G.A., Dubé, J.J., Goodpaster, B.H., O'Doherty, R.M., Ambrosio, F. Skeletal muscle as a regulator of the longevity protein, Klotho. Frontiers in Physiology. 2014; 5: 189.

Chartoumpekis, D.V., Palliyaguru, D.L., Wakabayashi, N., Khoo, N.K., Schoiswohl, G., O'Doherty, R.M., Kensler, T.W. Notch intracellular domain overexpression in adipocytes confers lipodystrophy in mice. Molecular Metabolism. 2015; 4(7): 543-50.

Edmunds, L.R., Otero, P.A., Sharma, L., D'Souza, S., Dolezal J.M., David, S., Lu, J., Lamm, L., Basantani, M., Zhang, P., Sipula, I.J., Li, L., Zeng, X., Ding, Y., Ding, F., Beck, M.E., Vockley, J., Monga, S.P., Kershaw, E.E., O'Doherty, R.M., Kratz L.E., Yates N.A., Goetzman E.P., Scott, D., Duncan A.W., Prochownik, E.V. Abnormal lipid processing but normal long-term repopulation potential of myc-/- hepatocytes. Oncotarget. 2016.

Schoiswohl, G., Stefanovic-Racic, M., Menke, M.N., Wills, R.C., Surlow, B.A., Basantani, M.K., Sitnick, M.T., Cai, L., Yazbeck, C.F., Stolz, D.B., Pulinilkunnil, T., O'Doherty, R.M., Kershaw, E.E. Impact of Reduced ATGL-Mediated Adipocyte Lipolysis on Obesity-Associated Insulin Resistance and Inflammation in Male Mice. Endocrinology. 2015; 156(10): 3610-24.

Sponsored Research/Activities
Title: Research Training in Diabetes and Endocrinology
Role: Principal Investigator
Funding Agency: National Institute of Diabetes, Digestive, & Kidney Disease
Grant Number: T32 DK007052
Start Year: 2016
End Year: 2021

Title: Dendritic Cells and Obesity
Role: Principal Investigator
Funding Agency: National Institute of Diabetes, Digestive, & Kidney Disease
Grant Number: R01 DK102839
Start Year: 2015
End Year: 2019

Title: Leptin Action and Macrophages
Role: Principal Investigator
Funding Agency: National Institute of Diabetes, Digestive, & Kidney Disease
Grant Number: R01 DK072162
Start Year: 2011
End Year: 2016

Title: Research Training in Diabetes and Endocrinology
Role: Principal Investigator
Funding Agency: National Institute of Diabetes, Digestive, & Kidney Disease
Grant Number: T32 DK007052
Start Year: 2010
End Year: 2016

Title: Regulation of Fuel Utilization by Lysine Acetylation in the Failing Heart
Role: Co-Investigator
Funding Agency: National Heart, Lung, & Blood Institute
Grant Number: R01 HL132917
Start Year: 2017
End Year: 2021

Title: Cellular and Molecular Mechanisms of HSC Dysfunction in Chronic Inflammation
Role: Co-Investigator
Funding Agency: National Institute of Allergy & Infectious Diseases
Grant Number: R56 AI079047
Start Year: 2015
End Year: 2016

Notable Achievements
Editorial Board, American Journal of Physiology (Endo/Metabol), 2010-present